Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 May 15;64(10):1463.
doi: 10.1093/cid/cix213.

Reply to Ozaras et al

Mark S Sulkowski  1 , Diana M Brainard  2 , Jenny C Yang  2 , Edward J Gane  3
Affiliations
Comment

Reply to Ozaras et al

Mark S Sulkowski et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ozaras R, Balkan II, Yemisen M et al. . Reactivation of hepatitis B virus following treatment of hepatitis C virus infection in coinfected patients. Clin Infect Dis 2017; 64:1461–2. - PubMed
    1. Sulkowski MS, Chuang WL, Kao JH et al. . No evidence of reactivation of hepatitis B virus among patients treated with ledipasvir-sofosbuvir for hepatitis C virus infection. Clin Infect Dis 2016; 63:1202–4. - PMC - PubMed
    1. Bersoff-Matcha S, Cao K, Jason M et al. . Hepatitis B reactivation associated with direct acting antiviral therapy for hepatitis C: a review of spontaneous post-marketing cases. Presented at the 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016, Boston, MA, 11–15 November 2016. [Abstract LB-17].
    1. Liu C-H, Liu C-J, Su T-H et al. . Hepatitis B virus reactivations in patients receiving interferon-free direct acting antiviral agents for chronic hepatitis C virus infection. Presented at the 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016, Boston, MA, 11–15 November 2016. [Abstract 831].
    1. World Health Organization. Over 1 million treated with highly effective hepatitis C medicines. Available at: http://www.who.int/mediacentre/news/releases/2016/hepatitis-c-medicines/en/. Accessed 15 February 2017.